These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
188 related items for PubMed ID: 6098878
21. Levels of CCK immunoreactivity and dopamine in the nucleus accumbens after 6-hydroxydopamine lesions of the ventral tegmental area and the nucleus accumbens. Igarashi Y, Wiegant VM, Van Ree JM. Neuropeptides; 1989; 14(2):71-6. PubMed ID: 2812290 [Abstract] [Full Text] [Related]
22. Effects of long-term haloperidol treatment on the responsiveness of accumbens neurons to cholecystokinin and dopamine: electrophysiological and radioligand binding studies in the rat. Debonnel G, Gaudreau P, Quirion R, de Montigny C. J Neurosci; 1990 Feb; 10(2):469-78. PubMed ID: 2137531 [Abstract] [Full Text] [Related]
23. Similar potencies of CCK-8 and its analogue BOC(Nle28;Nle31)CCK27-33 on the self-stimulation behaviour both are antagonized by a newly synthesized cyclic CCK analogue. Heidbreder C, Roques BP, De Witte P. Neuropeptides; 1989 Feb; 13(2):89-94. PubMed ID: 2739884 [Abstract] [Full Text] [Related]
24. Extracellular dopamine in the anterior nucleus accumbens is distinctly affected by ventral tegmental area administration of cholecystokinin and apomorphine: data from in vivo voltammetry. Reum T, Fink H, Marsden CA, Morgenstern R. Neuropeptides; 1998 Apr; 32(2):161-6. PubMed ID: 9639255 [Abstract] [Full Text] [Related]
25. The effects of cholecystokinin (CCK-8) on dopamine-containing nerve terminals in the caudate nucleus and nucleus accumbens of the anesthetized rat: an in vivo electrochemical study. Gerhardt GA, Friedemann M, Brodie MS, Vickroy TW, Gratton AP, Hoffer BJ, Rose GM. Brain Res; 1989 Oct 09; 499(1):157-63. PubMed ID: 2804664 [Abstract] [Full Text] [Related]
26. Nucleus accumbens cholecystokinin (CCK) can either attenuate or potentiate amphetamine-induced locomotor activity: evidence for rostral-caudal differences in accumbens CCK function. Vaccarino FJ, Rankin J. Behav Neurosci; 1989 Aug 09; 103(4):831-6. PubMed ID: 2765186 [Abstract] [Full Text] [Related]
27. Mesolimbic dopamine projection modulates amygdala-evoked EPSP in nucleus accumbens neurons: an in vivo study. Yim CY, Mogenson GJ. Brain Res; 1986 Mar 26; 369(1-2):347-52. PubMed ID: 3008939 [Abstract] [Full Text] [Related]
29. Effects of administration of cholecystokinin into the VTA on DA overflow in nucleus accumbens and amygdala of freely moving rats. Hamilton ME, Freeman AS. Brain Res; 1995 Aug 07; 688(1-2):134-42. PubMed ID: 8542299 [Abstract] [Full Text] [Related]
31. Acute effects of methamphetamine applied microiontophoretically to nucleus accumbens neurons in rats. Hara M, Akaike A, Sasa M, Takaori S. Neurosci Res; 1987 Apr 07; 4(4):279-90. PubMed ID: 2885796 [Abstract] [Full Text] [Related]
32. Muscarinic receptor blockade in the ventral tegmental area attenuates cocaine enhancement of laterodorsal tegmentum stimulation-evoked accumbens dopamine efflux in the mouse. Lester DB, Miller AD, Blaha CD. Synapse; 2010 Mar 07; 64(3):216-23. PubMed ID: 19862686 [Abstract] [Full Text] [Related]
37. Antagonism of footshock stress-induced inhibition of intracranial self-stimulation by naloxone or methamphetamine. Kamata K, Yoshida S, Kameyama T. Brain Res; 1986 Apr 16; 371(1):197-200. PubMed ID: 3011201 [Abstract] [Full Text] [Related]
38. Hippocampus modulates self-stimulation reward from the ventral tegmental area in the rat. Van Wolfswinkel L, Van Ree JM. Brain Res; 1984 Nov 19; 322(1):162-6. PubMed ID: 6518367 [Abstract] [Full Text] [Related]
39. Opposite effects of prefrontal cortex and nucleus accumbens infusions of flupenthixol on stimulant-induced locomotion and brain stimulation reward. Duvauchelle CL, Levitin M, MacConell LA, Lee LK, Ettenberg A. Brain Res; 1992 Mar 27; 576(1):104-10. PubMed ID: 1515903 [Abstract] [Full Text] [Related]